The APS Phenotyping Study

20 Feb 20264 min read0 viewsOBSERVATIONAL Trial

GIST

RECRUITING · OBSERVATIONAL · ARDS · Enrollment 4000 · Sponsor: Vanderbilt University Medical Center

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Infectious Disease on 20 Feb 2026. The item focuses on The APS Phenotyping Study. Open the detail page to review the full original feed content.

Source Reference

Read the full original publication from the source journal or publisher link below.

DOI

NCT06521502

Open Original Source More Feed Items

Related by Condition/Drug

Front ImmunolRelated by Conditionsepsis

Complement in acute kidney injury: a convergent pathogenic pathway in multifactorial renal damage

Infectious Disease • 22 May 2026

Front ImmunolRelated by Conditionsepsis

Neutrophil immunometabolism in ACLF and sepsis: mechanisms, dysfunction, and therapeutic opportunities

Infectious Disease • 22 May 2026

ClinicalTrialsRelated by Conditionsepsis

A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy

Infectious Disease • 22 Apr 2026

ClinicalTrialsRelated by Conditionsepsis

Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk Infants in NICU.

Infectious Disease • 25 Mar 2026

Lan IDRelated by Conditionsepsis

Correction to ATLAS Trial on HIV-Related Sepsis Therapy in Tanzania and Uganda

Infectious Disease • 02 Mar 2026

BMJ OpenRelated by Conditionsepsis

Knowledge and attitudes towards perioperative pulmonary embolism in major orthopaedic surgery patients: a cross-sectional study in Shanghai

Research Highlights • 14 May 2026

Feed Metadata

Source

ClinicalTrials.gov